POLYMORPHISM IN THE APO(A) GENE PREDICT RESPONSIVENESS TO ACETYLSALICYLIC ACID TREATMENT
Patent №
US 7,943,317
Granted
2011-05-17
Filed 2008
Owner
APPLERA CORPORATION
+3 more
Lab
—
AI components
1
evo
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
12118060
This invention relates to nucleotide polymorphisms in the human Apo(a) gene and to the use of Apo(a) nucleotide polymorphisms in identifying whether a human subject will respond or not to treatment with acetylsalicylic acid.
Evolutionary computationC12Q 1/6883A61K 31/616A61P 7/02A61P 9/00A61P 9/10C12Q 1/6876G01N 33/92C12Q 2600/106+9 more
AI classification
Evolutionary computation0.74
Vision0.00
Natural language0.00
AI hardware0.00
Machine learning0.00
Speech0.00
Planning0.00
Knowledge representation0.00
Ownership
APPLERA CORPORATION
assignment · 213490331
BRIGHAM AND WOMEN'S HOSPITAL, INC., THE
assignment · 213520062
CELERA CORPORATION
assignment · 278780533
THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
assignment · 348420769
From the same owner
POLYMORPHISM IN THE APO(A) GENE PREDICT RESPONSIVENESS TO ACETYLSALICYLIC ACID TREATMENTUS 11,697,850 · 2023SYSTEM AND METHODS FOR INDEL IDENTIFICATION USING SHORT READ SEQUENCINGUS 11,538,557 · 2022DIFFERENTIAL DISSOCIATION AND MELTING CURVE PEAK DETECTIONUS 11,257,570 · 2022NANOWIRE-BASED SYSTEM FOR ANALYSIS OF NUCLEIC ACIDSUS 10,961,575 · 2021SYSTEMS AND METHODS FOR GENERATING AUTOMATED SOFTWARE WORKFLOW FOR BIOLOGICAL TESTINGUS 10,769,559 · 2020Computer Algorithm for Automatic Allele Determination from Fluorometer Genotyping DeviceUS 10,496,679 · 2019METHODS OF DETECTING TARGET NUCLEIC ACIDSUS 10,196,680 · 2019System For Genetic Surveillance and AnalysisUS 10,181,010 · 2019